Additional Details

  • Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)

    Paradigm Clinical Research Centers LLC
    Redding CA. 96001
    View Details

  • Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)

    Palmtree Clinical Research Inc.
    Palm Spring CA. 92262
    View Details

  • Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)

    Premier Pulmonary Critical Care and Sleep Medicine
    Denison TX. 75020
    View Details

  • Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)

    Renovatio Clinical
    Webster TX. 77598
    View Details

  • Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis

    Institut Universitaire de Cardiologie et de Pneumologie de Quebec - Université Laval
    Québec QC. G1V 4G5
    View Details

  • Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis

    Centre Hospitalier de l'Universite de Montreal
    Montreal QC. H2X 0A9
    View Details

  • Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis

    Toronto General Hospital
    Toronto M5G 2C4
    View Details

  • Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis

    Vancouver General Hospital
    Vancouver BC. V5Z 1M9
    View Details

  • Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis

    Centre d'investigation Clinique Mauricie
    Trois-Rivières QC. G8T 7A1
    View Details

  • Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis

    Dynamic Drug Advancement Ltd.
    Ajax ON. L1S 2J5
    View Details

  • Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis

    Dr. Anil Dhar Medicine Professional Corporation
    Windsor N8X 5A6
    View Details

  • Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis

    Henry Ford Hospital /ID# 277843
    Detroit MI. 48202
    View Details

  • Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis

    Jefferson Health Honickman Center /ID# 279127
    Philadelphia PA. 19107
    View Details

  • Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis

    The University of Alabama at Birmingham /ID# 277613
    Birmingham AL. 35233
    View Details

  • Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis

    Inova Fairfax Hospital /ID# 278469
    Falls Church VA. 22042
    View Details

  • Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis

    University of Michigan Health System - Ann Arbor /ID# 279994
    Ann Arbor MI. 48109
    View Details

  • Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis

    Virginia Commonwealth University Medical Center /ID# 277992
    Richmond VA. 23219
    View Details

  • Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis

    Clinical Research Specialists - Kissimmee /ID# 279184
    Kissimmee FL. 34746
    View Details

  • Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis

    Centre d'Investigation Clinique Mauricie /ID# 277949
    Trois-Rivières QC. G8T 7A1
    View Details

  • Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis

    Hannibal Regional Hospital /ID# 277984
    Hannibal MO. 63401
    View Details